Sentiment Trading

Elekta AB’s Q4 2025 earnings report showed mixed results, with strong earnings overshadowed by concerns over order intake and the US market’s performance.

Elekta AB, a Swedish health care company, has demonstrated resilience and innovation in the sector, with a strong financial foundation and a clear vision for continued growth and leadership in cancer and brain disorder treatments.